A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Undergoing Corneal Transplant Surgery

NCT00764582 Phase 4 TERMINATED

Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)

Details

Lead sponsor	Santen Inc.
Phase	Phase 4
Status	TERMINATED
Enrolment	60
Start date	2008-09

Conditions

• Corneal Transplantation

Interventions

• 1.5% levofloxacin ophthalmic solution
• 0.5% moxifloxacin ophthalmic solution

Primary outcomes

• Concentration of levofloxacin and moxifloxacin in the corneal tissue — Time of surgery

Countries

United States